Search
for
Sort by
Research 481–510 of 893
- Bulge cells of human hair follicles: segregation, cultivation and properties
- Pediatric Psychocutaneous Disorders
- Clinical Approach to the Patient With Alopecia
- Female Adolescent Hair Disorders
- The expression of the gene <i>asebia</i> in the laboratory mouse: 3. Sebaceous glands
- Guidelines for clinical trials of frontal fibrosing alopecia: consensus recommendations from the International FFA Cooperative Group (IFFACG)*
- Dupilumab and Alopecia Areata: A Possible Combined or Disturbance Therapy? A Review of the Literature
- Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023
- Korean Consensus Criteria for the Severity Classification of Alopecia Areata
- Unilateral Straight Hair—A Symptom of Acquired Horner's Syndrome in a Neonate
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Janus Kinase inhibitors in dermatology: a review
- Bitemporal alopecia areata
- Diagnostic challenges in determining alopecia areata
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Managing androgenic alopecia with individualised homeopathic medicine and biochemic remedies- An evidence based single case report
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Hair for the Long Haul: Alopecia Areata Cases and Considerations
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- Prediction of Long-term Scalp Hair Regrowth at 24 Months in Patients with Alopecia Areata Receiving Ritlecitinib Treatment in the ALLEGRO Clinical Trial Program
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- Survey on Alopecia Areata Patients’ Reported Factors that Determine Severity of Alopecia Areata: A Nationwide Multicenter Study
- <i>DSG4</i> Gene Variants as a Cause of Hypotrichosis in the Child with Severe Atopic Dermatitis: Clinical Case
- FFA and Personal Care Product Use: A Systematic Review and Meta-Analysis
- Focal Asymptomatic Hair Loss in an Adolescent: A Case Report
- Vaccines, Infections, and Alopecia Areata
- Drug-induced hair pigmentation: Clinical perspectives and updates